BACKGROUND: The COVID-19 pandemic has led to widespread cancelation of electively scheduled surgeries, including for colorectal, pancreatic, and gastric cancer. The American College of Surgeons and the Society of Surgical Oncology have released guidelines for triage of these procedures. We seek to synthesize available evidence on delayed resection and oncologic outcomes, while also providing a critical assessment of the released guidelines. METHODS: A systematic review was conducted to identify literature between 2005 and 2020 investigating the impact of time to surgery on oncologic outcomes in colorectal, pancreatic, and gastric cancer. RESULTS: For colorectal cancer, 1066 abstracts were screened and 43 papers were included. In primarily resected colon cancer, delay over 30 to 40 days is associated with lower survival. In rectal cancer, time to surgery over 7 to 8 weeks following neoadjuvant therapy is associated with decreased survival. Three hundred ninety-four abstracts were screened for pancreatic cancer and nine studies were included. Two studies demonstrate increased unexpected progression with delayed surgery over 30 days. Out of 633 abstracts screened for gastric cancer, six studies were included. No identified study demonstrated worse survival with increased time to surgery. CONCLUSION: Moderate evidence suggests that delayed resection of colorectal cancer worsens survival; the impact of time to surgery on gastric and pancreatic cancer outcomes is uncertain. Early resection of gastrointestinal malignancies provides the best chance for curative therapy. During the COVID-19 pandemic, prioritization of procedures should account for available evidence on time to surgery and oncologic outcomes.
BACKGROUND: The COVID-19 pandemic has led to widespread cancelation of electively scheduled surgeries, including for colorectal, pancreatic, and gastric cancer. The American College of Surgeons and the Society of Surgical Oncology have released guidelines for triage of these procedures. We seek to synthesize available evidence on delayed resection and oncologic outcomes, while also providing a critical assessment of the released guidelines. METHODS: A systematic review was conducted to identify literature between 2005 and 2020 investigating the impact of time to surgery on oncologic outcomes in colorectal, pancreatic, and gastric cancer. RESULTS: For colorectal cancer, 1066 abstracts were screened and 43 papers were included. In primarily resected colon cancer, delay over 30 to 40 days is associated with lower survival. In rectal cancer, time to surgery over 7 to 8 weeks following neoadjuvant therapy is associated with decreased survival. Three hundred ninety-four abstracts were screened for pancreatic cancer and nine studies were included. Two studies demonstrate increased unexpected progression with delayed surgery over 30 days. Out of 633 abstracts screened for gastric cancer, six studies were included. No identified study demonstrated worse survival with increased time to surgery. CONCLUSION: Moderate evidence suggests that delayed resection of colorectal cancer worsens survival; the impact of time to surgery on gastric and pancreatic cancer outcomes is uncertain. Early resection of gastrointestinal malignancies provides the best chance for curative therapy. During the COVID-19 pandemic, prioritization of procedures should account for available evidence on time to surgery and oncologic outcomes.
Entities:
Keywords:
Colorectal cancer; Gastric cancer; Pancreatic cancer; Time to surgery
Authors: Moo Jung Kim; Jie-Hyun Kim; Yong Chan Lee; Jong Won Kim; Seung Ho Choi; Woo Jin Hyung; Sung Hoon Noh; Young Hoon Youn; Hyojin Park; Sang In Lee Journal: Ann Surg Oncol Date: 2013-10-08 Impact factor: 5.344
Authors: E Akgun; C Caliskan; O Bozbiyik; T Yoldas; M Sezak; S Ozkok; T Kose; B Karabulut; M Harman; O Ozutemiz Journal: Br J Surg Date: 2018-08-29 Impact factor: 6.939
Authors: Zhifei Sun; Mohamed A Adam; Jina Kim; Mithun Shenoi; John Migaly; Christopher R Mantyh Journal: J Am Coll Surg Date: 2016-01-20 Impact factor: 6.113
Authors: Luiz Felipe de Campos-Lobato; Daniel P Geisler; Andre da Luz Moreira; Luca Stocchi; David Dietz; Matthew F Kalady Journal: J Gastrointest Surg Date: 2010-12-08 Impact factor: 3.452
Authors: S Sanjeevi; T Ivanics; L Lundell; N Kartalis; Å Andrén-Sandberg; J Blomberg; M Del Chiaro; C Ansorge Journal: Br J Surg Date: 2015-11-17 Impact factor: 6.939
Authors: Sarah S Lee; Danial Ceasar; Benjamin Margolis; Pooja Venkatesh; Kevin Espino; Deanna Gerber; Leslie R Boyd Journal: Gynecol Oncol Rep Date: 2022-05-10
Authors: Farah Ballout; Reem Daouk; Joseph Azar; Michael Timonian; Tarek Araji; Hisham F Bahmad; Wassim Abou-Kheir Journal: SN Compr Clin Med Date: 2020-09-30
Authors: Eva J A Morris; Raphael Goldacre; Enti Spata; Marion Mafham; Paul J Finan; Jon Shelton; Mike Richards; Katie Spencer; Jonathan Emberson; Sam Hollings; Paula Curnow; Dominic Gair; David Sebag-Montefiore; Chris Cunningham; Matthew D Rutter; Brian D Nicholson; Jem Rashbass; Martin Landray; Rory Collins; Barbara Casadei; Colin Baigent Journal: Lancet Gastroenterol Hepatol Date: 2021-01-15
Authors: Concetta Elisa Onesti; Marco Tagliamento; Giuseppe Curigliano; Nadia Harbeck; Rupert Bartsch; Hans Wildiers; Vivianne Tjan-Heijnen; Miguel Martin; Sylvie Rottey; Daniele Generali; Mario Campone; Massimo Cristofanilli; Lajos Pusztai; Marc Peeters; Guy Berchem; Javier Cortes; Thomas Ruhstaller; Eva Ciruelos; Hope S Rugo; Guy Jerusalem Journal: JCO Glob Oncol Date: 2021-02
Authors: Ju Yeon Choi; In Ja Park; Hyun Gu Lee; Eunhae Cho; Young Il Kim; Chan Wook Kim; Yong Sik Yoon; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim Journal: Cancers (Basel) Date: 2021-05-06 Impact factor: 6.639